PortfoliosLab logoPortfoliosLab logo
CAH vs. IDXX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CAH vs. IDXX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cardinal Health, Inc. (CAH) and IDEXX Laboratories, Inc. (IDXX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CAH achieves a -0.01% return, which is significantly higher than IDXX's -17.05% return. Over the past 10 years, CAH has underperformed IDXX with an annualized return of 13.19%, while IDXX has yielded a comparatively higher 20.23% annualized return.


CAH

1D
-0.60%
1M
11.34%
YTD
-0.01%
6M
3.32%
1Y
33.66%
3Y*
35.29%
5Y*
31.41%
10Y*
13.19%

IDXX

1D
-0.18%
1M
0.19%
YTD
-17.05%
6M
-20.59%
1Y
6.91%
3Y*
7.57%
5Y*
-0.19%
10Y*
20.23%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CAH vs. IDXX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CAH
Cardinal Health, Inc.
-0.01%76.25%19.01%34.15%54.08%-0.40%10.09%18.04%-24.50%-12.65%
IDXX
IDEXX Laboratories, Inc.
-17.05%63.63%-25.51%36.06%-38.04%31.73%91.43%40.38%18.95%33.35%

Correlation

The correlation between CAH and IDXX is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.15

Correlation (3Y)
Calculated over the trailing 3-year period

0.19

Correlation (5Y)
Calculated over the trailing 5-year period

0.21

Correlation (10Y)
Calculated over the trailing 10-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Jun 24, 1991

0.24

Fundamentals

EPS

CAH:

$6.55

IDXX:

$18.08

PE Ratio

CAH:

31.22

IDXX:

31.04

PEG Ratio

CAH:

0.74

IDXX:

2.68

PS Ratio

CAH:

0.19

IDXX:

7.65

Total Revenue (TTM)

CAH:

$250.55B

IDXX:

$4.45B

Gross Profit (TTM)

CAH:

$9.23B

IDXX:

$2.76B

EBITDA (TTM)

CAH:

$2.79B

IDXX:

$1.52B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CAH vs. IDXX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CAH
CAH Risk / Return Rank: 7474
Overall Rank
CAH Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
CAH Sortino Ratio Rank: 7575
Sortino Ratio Rank
CAH Omega Ratio Rank: 7575
Omega Ratio Rank
CAH Calmar Ratio Rank: 7272
Calmar Ratio Rank
CAH Martin Ratio Rank: 7474
Martin Ratio Rank

IDXX
IDXX Risk / Return Rank: 4848
Overall Rank
IDXX Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
IDXX Sortino Ratio Rank: 4949
Sortino Ratio Rank
IDXX Omega Ratio Rank: 4747
Omega Ratio Rank
IDXX Calmar Ratio Rank: 4848
Calmar Ratio Rank
IDXX Martin Ratio Rank: 4848
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CAH vs. IDXX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cardinal Health, Inc. (CAH) and IDEXX Laboratories, Inc. (IDXX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CAHIDXXDifference
Sharpe ratioReturn per unit of total volatility

+0.96

Sortino ratioReturn per unit of downside risk

+1.23

Omega ratioGain probability vs. loss probability

1.26

1.09

+0.17

Calmar ratioReturn relative to maximum drawdown

1.66

0.22

+1.43

Martin ratioReturn relative to average drawdown

4.37

0.46

+3.91

CAH vs. IDXX - Sharpe Ratio Comparison

The current CAH Sharpe Ratio is 1.13, which is higher than the IDXX Sharpe Ratio of 0.17. The chart below compares the historical Sharpe Ratios of CAH and IDXX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CAHIDXXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.13

0.17

+0.96

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

1.25

-0.01

+1.26

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.45

0.62

-0.16

Sharpe Ratio (All Time)

Calculated using the full available price history

0.56

0.51

+0.06

Drawdowns

CAH vs. IDXX - Drawdown Comparison

The maximum CAH drawdown since its inception was -61.93%, smaller than the maximum IDXX drawdown of -81.42%. Use the drawdown chart below to compare losses from any high point for CAH and IDXX.


Loading charts...

Drawdown Indicators


CAHIDXXDifference

Max Drawdown

Largest peak-to-trough decline

-61.93%

-81.42%

+19.49%

Max Drawdown (1Y)

Largest decline over 1 year

-20.42%

-31.04%

+10.62%

Max Drawdown (3Y)

Largest decline over 3 years

-20.42%

-37.41%

+16.99%

Max Drawdown (5Y)

Largest decline over 5 years

-22.80%

-54.00%

+31.20%

Max Drawdown (10Y)

Largest decline over 10 years

-46.13%

-54.00%

+7.87%

Current Drawdown

Current decline from peak

-10.83%

-26.81%

+15.98%

Average Drawdown

Average peak-to-trough decline

-15.94%

-21.00%

+5.06%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.72%

15.03%

-7.31%

Volatility

CAH vs. IDXX - Volatility Comparison

The current volatility for Cardinal Health, Inc. (CAH) is 6.59%, while IDEXX Laboratories, Inc. (IDXX) has a volatility of 8.57%. This indicates that CAH experiences smaller price fluctuations and is considered to be less risky than IDXX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CAHIDXXDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.59%

8.57%

-1.98%

Volatility (6M)

Calculated over the trailing 6-month period

19.73%

19.89%

-0.16%

Volatility (1Y)

Calculated over the trailing 1-year period

29.99%

41.46%

-11.47%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.19%

35.28%

-10.09%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

29.23%

33.01%

-3.78%

Dividends

CAH vs. IDXX - Dividend Comparison

CAH's dividend yield for the trailing twelve months is around 1.00%, while IDXX has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
CAH
Cardinal Health, Inc.
1.00%0.99%1.28%1.98%2.57%3.80%3.62%3.80%4.24%3.00%2.41%1.68%
IDXX
IDEXX Laboratories, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

CAH vs. IDXX - Financials Comparison

This section allows you to compare key financial metrics between Cardinal Health, Inc. and IDEXX Laboratories, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00B20.00B30.00B40.00B50.00B60.00B70.00B20222023202420252026
60.94B
1.14B
(CAH) Total Revenue
(IDXX) Total Revenue
Values in USD except per share items

CAH vs. IDXX - Profitability Comparison

The chart below illustrates the profitability comparison between Cardinal Health, Inc. and IDEXX Laboratories, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%10.0%20.0%30.0%40.0%50.0%60.0%20222023202420252026
4.1%
63.4%
Portfolio components
CAH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cardinal Health, Inc. reported a gross profit of 2.50B and revenue of 60.94B. Therefore, the gross margin over that period was 4.1%.

IDXX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported a gross profit of 722.74M and revenue of 1.14B. Therefore, the gross margin over that period was 63.4%.

CAH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cardinal Health, Inc. reported an operating income of 509.00M and revenue of 60.94B, resulting in an operating margin of 0.8%.

IDXX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported an operating income of 362.59M and revenue of 1.14B, resulting in an operating margin of 31.8%.

CAH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cardinal Health, Inc. reported a net income of 399.00M and revenue of 60.94B, resulting in a net margin of 0.7%.

IDXX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported a net income of 278.45M and revenue of 1.14B, resulting in a net margin of 24.4%.


Frequently Asked Questions


CAH and IDXX have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IDXX has higher volatility (8.57%) compared to CAH (6.59%). In terms of maximum drawdown, CAH dropped -61.93% vs IDXX's -81.42%.

CAH currently has the higher Sharpe Ratio (1.13 vs 0.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CAH and IDXX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer